Cargando…

p53MutaGene: an online tool to estimate the effect of p53 mutational status on gene regulation in cancer

p53MutaGene is the first online tool for statistical validation of hypotheses regarding the effect of p53 mutational status on gene regulation in cancer. This tool is based on several large-scale clinical gene expression data sets and currently covers breast, colon and lung cancers. The tool detects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amelio, I, Knight, R A, Lisitsa, A, Melino, G, Antonov, A V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823943/ https://www.ncbi.nlm.nih.gov/pubmed/26986515 http://dx.doi.org/10.1038/cddis.2016.42

Ejemplares similares

SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer
por: Amelio, I, et al.
Publicado: (2016)

Do Mutations Turn p53 into an Oncogene?
por: Pitolli, Consuelo, et al.
Publicado: (2019)

Commensal microbes and p53 in cancer progression
por: Celardo, Ivana, et al.
Publicado: (2020)

Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

NRF2 and p53: Januses in cancer?
por: Rotblat, Barak, et al.
Publicado: (2012)

p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer
por: Zampieri, Carlotta, et al.
Publicado: (2022)

In vivo mutagenicity assessment of styrene in MutaMouse liver and lung
por: Murata, Yasumasa, et al.
Publicado: (2023)

p53 regulates expression of nuclear envelope components in cancer cells
por: Panatta, Emanuele, et al.
Publicado: (2022)

NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
por: Mammarella, Eleonora, et al.
Publicado: (2021)

p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms
por: Pitolli, Consuelo, et al.
Publicado: (2019)

Polypharmacology of small molecules targeting the ubiquitin–proteasome and ubiquitin-like systems
por: Amelio, Ivano, et al.
Publicado: (2015)

p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression
por: Amelio, Ivano, et al.
Publicado: (2018)

Role of p53 Serine 46 in p53 Target Gene Regulation
por: Smeenk, Leonie, et al.
Publicado: (2011)

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
por: Gorgoulis, V. G., et al.
Publicado: (1998)

Gene expression patterns associated with p53 status in breast cancer
por: Troester, Melissa A, et al.
Publicado: (2006)

The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicals
por: Cox, Julie A., et al.
Publicado: (2019)

Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation.
por: el-Mahdani, N., et al.
Publicado: (1997)

p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer
por: Butera, Alessio, et al.
Publicado: (2022)

Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots
por: Liapis, Evagelos, et al.
Publicado: (2008)

p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
por: Choi, S. W., et al.
Publicado: (1994)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

ZNF185 is a p53 target gene following DNA damage
por: Smirnov, Artem, et al.
Publicado: (2018)

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma
por: Boldrin, Elisa, et al.
Publicado: (2023)

MutaNET: a tool for automated analysis of genomic mutations in gene regulatory networks
por: Hollander, Markus, et al.
Publicado: (2018)

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2023)

Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma
por: Doak, S H, et al.
Publicado: (2003)

p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan
por: Hsieh, L-L, et al.
Publicado: (2005)

Necdin, a p53-Target Gene, Is an Inhibitor of p53-Mediated Growth Arrest
por: Lafontaine, Julie, et al.
Publicado: (2012)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma
por: Kudo, Itsuhiro, et al.
Publicado: (2017)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
por: Sung, You-Na, et al.
Publicado: (2022)

How mutant p53 empowers Foxh1 fostering leukaemogenesis?
por: Amelio, Ivano
Publicado: (2019)

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
por: Dix, B., et al.
Publicado: (1994)

p53 Status in Multiple Human Urothelial Cancers: Assessment for Clonality by the Yeast p53 Functional Assay in Combination with p53 Immunohistochemistry
por: Yamamoto, Shinji, et al.
Publicado: (2000)

Lysine-specific modifications of p53: a matter of life and death?
por: Marouco, Diana, et al.
Publicado: (2013)

Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993)

MutaCYP: Classification of missense mutations in human cytochromes P450
por: Fechter, Kenneth, et al.
Publicado: (2014)

Census and evaluation of p53 target genes
por: Fischer, M
Publicado: (2017)

Preferential translation of p53 target genes
por: Hisaoka, Miharu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gbn09rom1mv5kgtth371voikgh